Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive solid tumours with an estimated 5-year overall survival rate of 7% for all stages combined. In this highly resistant disease that is located in the vicinity of many radiosensitive organs, the role of radiotherapy (RT) and ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchart, Christelle, Navez, Julie, Closset, Jean, Hendlisz, Alain, Van Gestel, Dirk, Moretti, Luigi, Van Laethem, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343368/
https://www.ncbi.nlm.nih.gov/pubmed/32684987
http://dx.doi.org/10.1177/1758835920936093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343368/
https://www.ncbi.nlm.nih.gov/pubmed/32684987
http://dx.doi.org/10.1177/1758835920936093

Ejemplares similares